Ric Kayne Issues Letter To Athira Shareholders Highlighting Why Immediate Board Change Is Required

Dear Fellow Athira Shareholders,

As you know, the Athira Pharma, Inc. (NASDAQ: ATHA) (“Athira” or the “Company”) annual meeting is only a few weeks away.  As one of the Company’s largest and longest-tenured shareholders, I am taking this opportunity to highlight why I believe, after numerous recent missteps by Athira’s Board of Directors (the “Board”), c…